The US journal "Science" has named the development of the drug Lenacapavir as this year's "Breakthrough of the Year". The ...
Lenacapavir, a treatment administered subcutaneously every six months, is capable of preventing infection with very high ...
LOS ANGELES, Dec. 13 (Xinhua) -- An injectable HIV drug with novel mechanism was named on Thursday by the influential U.S. journal "Science" as Breakthrough of the Year. The drug, named lenacapavir, ...
But doing so still requires “substantial breakthroughs in synthetic cell research”, the scientists said. HIV gamechanger: Lenacapavir study participant explains Although the capability to engineer ...
That's the title that Science magazine is bestowing upon the medication called lenacapavir — a twice yearly injectable that ...